This is a past event. Registration is closed. View other Innovation and Value Initiative events.
Where
Venable LLP
600 Massachusetts Avenue, NW
Civiletti Conference Room
Washington, District of Columbia
Event Details
Join us at the 5th Annual IVI Methods Summit as we delve into the forefront of patient-centered health technology assessment (HTA) to explore its future direction.
The Summit aims to bridge the gap between theory and practice by exploring actionable steps that stakeholders can take to implement patient-centered HTA effectively. Attendees will have the opportunity to engage in thought-provoking discussions, explore patient-focused methodologies, network with thought leaders, and contribute to shaping the future landscape of HTA.
Don't miss this unique opportunity to be at the forefront of patient-centered health technology assessment and play a vital role in advancing research, policy, and practice. Join us and be part of the conversation that is transforming the future of healthcare.
Event Details
Speakers
Zubair Ansari
Executive Director of Cancer Support Community
Anton Avanceña, PhD
Assistant Professor of Health Outcomes and Internal Medicine at The University of Texas at Austin
Jonathan Campbell, MS, PhD
Chief Science Officer at National Pharmaceutical Council
Richard Chapman, PhD
Chief Science Officer at Innovation and Value Initiative
Sneha Dave
Executive Director of Generation Patient
Ilisa Halpern Paul, MPP
Senior Policy Advisor at Venable LLP
Annie Kennedy
Chief of Policy, Advocacy and Patient Engagement at EveryLife Foundation for Rare Diseases
Bellinda King-Kallimanis, PhD
Senior Director of Patient-Focused Research at LUNGevity Foundation
Meng Li, PhD
Assistant Professor at CEVR, Tufts Medical Center
Kistein Monkhouse, MPA
Founder of Patient Orator
Eberechukwu Onukwugha, MS, PhD
Professor at University of Maryland School of Pharmacy
Jason Spangler, MD, MPH, FACPM
Chief Executive Officer at Innovation and Value Initiative
Dionne Stalling
Executive Director of Rare And Black
Simu Thomas, PhD
VP and Global Head HEOR and GMC at Alexion, AstraZeneca Rare Disease
Melanie Whittington, PhD, MS
Senior Fellow at CEVR, Tufts Medical Center
